All Stories

  1. Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure
  2. A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies With Fasting Insulin in Type B Insulin Resistance
  3. Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters
  4. Effect of High-Dose Selenium on Postoperative Organ Dysfunction and Mortality in Cardiac Surgery Patients
  5. High throughput drug screening identifies resveratrol as suppressor of hepatic SELENOP expression
  6. Fatal congenital copper transport defect caused by a homozygous likely pathogenic variant of SLC31A1
  7. Association of COVID-19 mortality with serum selenium, zinc and copper: Six observational studies across Europe
  8. Seizures, ataxia and parvalbumin-expressing interneurons respond to selenium supply in Selenop-deficient mice
  9. Selenoprotein P – Selenium transport protein, enzyme and biomarker of selenium status
  10. Selenium Status and Supplementation Effects in Pregnancy—A Study on Mother–Child Pairs from a Single-Center Cohort
  11. Assessment of the Effect of Selenium Supplementation on Production of Selected Cytokines in Women with Hashimoto’s Thyroiditis
  12. Increased Incidence of Hashimoto Thyroiditis in Selenium Deficiency: A Prospective 6-Year Cohort Study
  13. Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension
  14. Autoimmunity to selenoprotein P predicts breast cancer recurrence
  15. Serum Free Zinc Is Associated With Vaccination Response to SARS-CoV-2
  16. Selenium Status in Paediatric Patients with Neurodevelopmental Diseases
  17. Humoral immune response to COVID-19 mRNA vaccination in relation to selenium status
  18. Free Zinc as a Predictive Marker for COVID-19 Mortality Risk
  19. Editorial: Selenium and Selenoproteins in Brain Development, Function, and Disease
  20. Selenium Deficiency in COVID-19—A Possible Long-Lasting Toxic Relationship
  21. High‐dose supplementation of selenium in left ventricular assist device implant surgery: A double‐blinded, randomized controlled pilot trial
  22. Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
  23. Natural Autoimmunity to Selenoprotein P Impairs Selenium Transport in Hashimoto’s Thyroiditis
  24. Insulin Receptor Autoantibody–mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease
  25. Pronounced Trace Element Variation in Follicular Fluids of Subfertile Women Undergoing Assisted Reproduction
  26. Relationship between Vitamin D Status and Antibody Response to COVID-19 mRNA Vaccination in Healthy Adults
  27. Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
  28. The Nutritional Supply of Iodine and Selenium Affects Thyroid Hormone Axis Related Endpoints in Mice
  29. Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations
  30. Ageing-associated effects of a long-term dietary modulation of four trace elements in mice
  31. Course and Survival of COVID-19 Patients with Comorbidities in Relation to the Trace Element Status at Hospital Admission
  32. Copper Isotopes and Copper to Zinc Ratio as Possible Biomarkers for Thyroid Cancer
  33. Maternal Thyroid Hormone Programs Cardiovascular Functions in the Offspring
  34. Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19—A Preventable Trigger for Autoimmune Disease
  35. Positive effects of selenium supplementation in women with newly diagnosed Hashimoto's thyroiditis in an area with low selenium status
  36. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS
  37. Relation of Serum Copper Status to Survival in COVID-19
  38. Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury
  39. Predicting neurological recovery after traumatic spinal cord injury by time-resolved analysis of monocyte subsets
  40. Relation of Serum Copper Status to Survival in COVID-19
  41. Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
  42. Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
  43. Selenium supplementation to improve bone health in postmenopausal women: the SeMS three-arm RCT
  44. Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial
  45. Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
  46. Selenium Status Should Be Assessed
  47. Trace element profile and incidence of type 2 diabetes, cardiovascular disease and colorectal cancer: results from the EPIC-Potsdam cohort study
  48. Serum Selenium Status as a Diagnostic Marker for the Prognosis of Liver Transplantation
  49. PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
  50. Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker
  51. Serum Selenium Status as Diagnostic Marker for Prognosis in Liver Transplantation
  52. Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease
  53. Se Status Prediction by Food Intake as Compared to Circulating Biomarkers in a West Algerian Population
  54. Copper interferes with selenoprotein synthesis and activity
  55. Selenium deficiency is linearly associated with hypoglycemia in healthy adults
  56. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case‐control study
  57. Selenium Deficiency Is Associated with Mortality Risk from COVID-19
  58. Selenium Deficiency is Associated with Mortality Risk from COVID-19
  59. Aging affects sex- and organ-specific trace element profiles in mice
  60. Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
  61. CD5L Constitutes a Novel Biomarker for Integrated Hepatic Thyroid Hormone Action
  62. Zinc Concentration Dynamics Indicate Neurological Impairment Odds after Traumatic Spinal Cord Injury
  63. Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite
  64. Copper and selenium status as biomarkers of neonatal infections
  65. Cross-sectional analysis of trace element status in thyroid disease
  66. Antagonistic Autoantibodies to Insulin-Like Growth Factor-1 Receptor Associate with Poor Physical Strength
  67. Selenium and Selenoprotein P Deficiency Correlates With Complications and Adverse Outcome After Major Trauma
  68. Selenium and copper status - potential signposts for neurological remission after traumatic spinal cord injury
  69. N- and O-Acetylated 3-Iodothyronamines Have No Metabolic or Thermogenic Effects in Male Mice
  70. The other view: the trace element selenium as a micronutrient in thyroid disease, diabetes, and beyond
  71. Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathy
  72. The Role of Magnesium in the Secondary Phase After Traumatic Spinal Cord Injury. A Prospective Clinical Observer Study
  73. Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers
  74. You’d Better Zinc—Trace Element Homeostasis in Infection and Inflammation
  75. Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery
  76. A Zinpyr-1-based Fluorimetric Microassay for Free Zinc in Human Serum
  77. Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death
  78. Selenium in Cardiac Surgery
  79. Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis
  80. Association of Selenoprotein and Selenium Pathway Genotypes with Risk of Colorectal Cancer and Interaction with Selenium Status
  81. Circulating levels of selenium-binding protein 1 (SELENBP1) are associated with risk for major adverse cardiac events and death
  82. Relation of selenium status to neuro-regeneration after traumatic spinal cord injury
  83. Expression of Selenoprotein Genes and Association with Selenium Status in Colorectal Adenoma and Colorectal Cancer
  84. Whole Blood Selenium Levels and Selenium Supplementation in Patients Treated in a Family Doctor Practice in Golßen (State of Brandenburg, Germany): A Laboratory Study
  85. Role of Selenium Intake for Risk and Development of Hyperthyroidism
  86. Selenium in Radiation Oncology—15 Years of Experiences in Germany
  87. Cow Milk Consumption Increases Iodine Status in Women of Childbearing Age in a Randomized Controlled Trial
  88. In vivo Effects of Repeated Thyronamine Administration in Male C57BL/6J Mice
  89. Severe selenium deficits in pregnant women irrespective of autoimmune thyroid disease in an area with marginal selenium intake
  90. Double-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves Hyperthyroidism
  91. Aminoglycoside-driven biosynthesis of selenium-deficient Selenoprotein P
  92. Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
  93. Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy
  94. The missing link? The potential role of selenium in the development of liver cancer and significance for the general population
  95. Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P
  96. Copper to Zinc Ratio as Disease Biomarker in Neonates with Early-Onset Congenital Infections
  97. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans
  98. Trace element and cytokine concentrations in patients with Fibrodysplasia Ossificans Progressiva (FOP): A case control study
  99. Dietary Selenium and Human Health
  100. A Nonradioactive DEHAL Assay for Testing Substrates, Inhibitors, and Monitoring Endogenous Activity
  101. Treatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients
  102. Selenoprotein Gene Nomenclature
  103. Factors impacting the aminoglycoside-induced UGA stop codon readthrough in selenoprotein translation
  104. Positive correlation of thyroid hormones and serum copper in children with congenital hypothyroidism
  105. Minireview: Insights Into the Structural and Molecular Consequences of the TSH-β Mutation C105Vfs114X
  106. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
  107. Selenium status in neonates with connatal infection
  108. Selenium Status Is Positively Associated with Bone Mineral Density in Healthy Aging European Men
  109. Association of antiepileptic drug usage, trace elements and thyroid hormone status
  110. Silychristin, a Flavonolignan Derived From the Milk Thistle, Is a Potent Inhibitor of the Thyroid Hormone Transporter MCT8
  111. Lack of Association between Selenium Status and Disease Severity and Activity in Patients with Graves' Ophthalmopathy
  112. Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease
  113. Regulation of Selenocysteine Content of Human Selenoprotein P by Dietary Selenium and Insertion of Cysteine in Place of Selenocysteine
  114. Chronic Kidney Disease Distinctly Affects Relationship Between Selenoprotein P Status and Serum Thyroid Hormone Parameters
  115. Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure
  116. Revised reference values for selenium intake
  117. An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases
  118. A Nonradioactive Uptake Assay for Rapid Analysis of Thyroid Hormone Transporter Function
  119. Strong induction of iodothyronine deiodinases by chemotherapeutic selenocompounds
  120. Gene-specific regulation of hepatic selenoprotein expression by interleukin-6
  121. Association between maternal micronutrient status, oxidative stress, and common genetic variants in antioxidant enzymes at 15 weeks׳ gestation in nulliparous women who subsequently develop preeclampsia
  122. IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo
  123. Selenium status in patients with autoimmune and non-autoimmune thyroid diseases from four European countries
  124. Secisbp2 Is Essential for Embryonic Development and Enhances Selenoprotein Expression
  125. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort
  126. Multicenter, Phase III Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology
  127. Selenoprotein P is the essential selenium transporter for bones
  128. Hypoxia reduces and redirects selenoprotein biosynthesis
  129. Selenoprotein P in seminal fluid is a novel biomarker of sperm quality
  130. Resting Energy Expenditure and the Effects of Muscle Wasting in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF)
  131. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies
  132. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study,,
  133. Serum selenium is low in newly diagnosed Graves’ disease: a population-based study
  134. Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology - a subgroup analysis of a multicenter, phase III trial
  135. Identification of thyroid hormone response elements in vivo using mice expressing a tagged thyroid hormone receptor α1
  136. Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study
  137. Autoantibodies to the IGF1 Receptor in Graves' Orbitopathy
  138. Bone Turnover and Bone Mineral Density Are Independently Related to Selenium Status in Healthy Euthyroid Postmenopausal Women
  139. Polymorphisms in Thioredoxin Reductase and Selenoprotein K Genes and Selenium Status Modulate Risk of Prostate Cancer
  140. Standardization of Misleading Immunoassay Based 25-Hydroxyvitamin D Levels with Liquid Chromatography Tandem-Mass Spectrometry in a Large Cohort Study
  141. Selenoprotein P Status Correlates to Cancer-Specific Mortality in Renal Cancer Patients
  142. Thyroid Function Is Maintained Despite Increased Oxidative Stress in Mice Lacking Selenoprotein Biosynthesis in Thyroid Epithelial Cells
  143. Identification of Iopanoic Acid as Substrate of Type 1 Deiodinase by a Novel Nonradioactive Iodide-Release Assay
  144. Serum copper as a novel biomarker for resistance to thyroid hormone
  145. Structure- and cell-specific effects of imidoselenocarbamates on selenoprotein expression and activity in liver cells in culture
  146. Selenium, selenoproteins and the thyroid gland: interactions in health and disease
  147. Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture
  148. Differential responses to selenomethionine supplementation by sex and genotype in healthy adults
  149. Disorders of selenium metabolism and selenoprotein function
  150. Determinants of selenium status in healthy adults
  151. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency
  152. Ovine pulmonary adenocarcinoma as an animal model of progressive lung cancer and the impact of nutritional selenium supply
  153. Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage
  154. Activation of mitochondrial energy metabolism protects against cardiac failure
  155. Effects of Selenium Status and Polymorphisms in Selenoprotein Genes on Prostate Cancer Risk in a Prospective Study of European Men
  156. Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology
  157. Thyroid Hormones Regulate Selenoprotein Expression and Selenium Status in Mice
  158. Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain
  159. Selenoprotein-Related Disease in a Young Girl Caused by Nonsense Mutations in theSBP2Gene
  160. The choice of biomarkers determines the selenium status in young German vegans and vegetarians
  161. Genetics and phenomics of selenoenzymes—How to identify an impaired biosynthesis?
  162. Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice
  163. Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
  164. Opposing effects of dietary sugar and saturated fat on cardiovascular risk factors and glucose metabolism in mitochondrially impaired mice
  165. Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon
  166. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration
  167. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium
  168. Serum selenium and selenoprotein P status in adult Danes – 8-year followup
  169. Selenium in Oncology: From Chemistry to Clinics
  170. Reduced Serum Selenoprotein P Concentrations in German Prostate Cancer Patients
  171. Transgenic mice expressing small interfering RNA against Gata4 point to a crucial role of Gata4 in the heart and gonads
  172. Interference of Endocrine Disrupters with Thyroid Hormone Receptor–Dependent Transactivation
  173. Selenium Supplementation Fails to Correct the Selenoprotein Synthesis Defect in Subjects with SBP2 Gene Mutations
  174. Down‐regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice
  175. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health
  176. V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis
  177. Think globally: Act locally
  178. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum
  179. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice
  180. Effect of age on sexually dimorphic selenoprotein expression in mice
  181. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3
  182. Neuronal and ependymal expression of selenoprotein P in the human brain
  183. Selenium-Dependent Pre- and Posttranscriptional Mechanisms Are Responsible for Sexual Dimorphic Expression of Selenoproteins in Murine Tissues
  184. Synthesis and Metabolism of Thyroid Hormones Is Preferentially Maintained in Selenium-Deficient Transgenic Mice
  185. Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans
  186. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice
  187. New insights into the physiological actions of selenoproteins from genetically modified mice
  188. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism
  189. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum
  190. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply
  191. Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney
  192. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic
  193. The Neurobiology of Selenium: Lessons from Transgenic Mice
  194. Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency
  195. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues
  196. Effect of endotoxin on expression of TNF receptors and transport of TNF-α at the blood-brain barrier of the rat
  197. Prolactin-Releasing Peptides Do Not Stimulate Prolactin Release in vivo
  198. Expression and Hormonal Regulation of Coactivator and Corepressor Genes
  199. Regulation of the Adenohypophyseal Thyrotropin-Releasing Hormone-Degrading Ectoenzyme by Estradiol1
  200. Thyrotropin-Releasing Hormone Gene Expression by Anterior Pituitary Cells in Long-Term Cultures Is Influenced by the Culture Conditions and Cell-to-Cell Interactions1
  201. Genomic Organization and Promoter Structure of the Human EXT1 Gene
  202. Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the thyrotropin-releasing hormone (TRH) receptor and the TRH-degrading ectoenzyme.
  203. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone.